- Home
- RHI vs PBH Comparison
RHI vs PBH Comparison
Compare RHI & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHI
- PBH
- Stock Information
- Founded
- RHI 1948
- PBH 1996
- Country
- RHI United States
- PBH United States
- Employees
- RHI N/A
- PBH N/A
- Industry
- RHI Professional Services
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- RHI Consumer Discretionary
- PBH Health Care
- Exchange
- RHI Nasdaq
- PBH Nasdaq
- Market Cap
- RHI 4.1B
- PBH 3.8B
- IPO Year
- RHI N/A
- PBH 2005
- Fundamental
- Price
- RHI $34.19
- PBH $65.60
- Analyst Decision
- RHI Hold
- PBH Buy
- Analyst Count
- RHI 5
- PBH 5
- Target Price
- RHI $49.80
- PBH $94.00
- AVG Volume (30 Days)
- RHI 2.0M
- PBH 454.5K
- Earning Date
- RHI 07-23-2025
- PBH 08-07-2025
- Dividend Yield
- RHI 6.90%
- PBH N/A
- EPS Growth
- RHI N/A
- PBH 4.18
- EPS
- RHI 1.75
- PBH 4.26
- Revenue
- RHI $5,569,026,000.00
- PBH $1,120,150,000.00
- Revenue This Year
- RHI N/A
- PBH $2.04
- Revenue Next Year
- RHI $3.51
- PBH $2.07
- P/E Ratio
- RHI $19.51
- PBH $15.39
- Revenue Growth
- RHI N/A
- PBH 0.63
- 52 Week Low
- RHI $34.06
- PBH $63.78
- 52 Week High
- RHI $78.41
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- RHI 22.10
- PBH 18.61
- Support Level
- RHI $38.90
- PBH $72.53
- Resistance Level
- RHI $43.26
- PBH $75.31
- Average True Range (ATR)
- RHI 1.20
- PBH 1.93
- MACD
- RHI -0.47
- PBH -0.63
- Stochastic Oscillator
- RHI 1.41
- PBH 13.31
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.